Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Mouse NT-4 ELISA Kit (AC3785)
Cat.#: ASET-2374
Specifications
Description Mouse NT-4 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of mouse NT-4 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.03 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 150-2400 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1226 Human Neogenin ELISA Kit (AC2637) Quantitative inquiry ASET-1730 Human Caspase-12 ELISA Kit (AC3141) Quantitative inquiry ASET-1985 Mouse Calpastatin ELISA Kit (AC3396) Quantitative inquiry ASET-1137 Rat SOX9 ELISA Kit (AC2548) Quantitative inquiry ASET-1042 Human Pannexin 1 ELISA Kit (AC2453) Quantitative inquiry ASET-1720 Rat JNK3 ELISA Kit (AC3131) Quantitative inquiry ASET-2468 Mouse SIRP alpha ELISA Kit (AC3879) Quantitative inquiry ASET-1459 Human KALRN ELISA Kit (AC2870) Quantitative inquiry ASET-1400 Mouse Semaphorin 3A ELISA Kit (AC2811) Quantitative inquiry ASET-1244 Mouse NT-4 ELISA Kit (AC2655) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket